Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Revenue Breakdown and Options Chain

Gain deeper insights into company revenues with a detailed analysis of revenue sources.
Explore the updated Options feature, providing in-depth data, and a 3D viewing option.

Last Close
Mar 28 04:00PM ET
1.03
Dollar change
+0.04
Percentage change
4.03
%
Index- P/E- EPS (ttm)-1.86 Insider Own21.68% Shs Outstand14.63M Perf Week-1.50%
Market Cap15.07M Forward P/E- EPS next Y-0.86 Insider Trans0.00% Shs Float11.46M Perf Month11.34%
Income-26.39M PEG- EPS next Q-0.32 Inst Own1.59% Short Float2.77% Perf Quarter-12.71%
Sales0.53M P/S28.43 EPS this Y9.68% Inst Trans-2.44% Short Ratio3.60 Perf Half Y-66.77%
Book/sh0.35 P/B2.91 EPS next Y48.81% ROA- Short Interest0.32M Perf Year-83.52%
Cash/sh0.75 P/C1.38 EPS next 5Y- ROE- 52W Range0.85 - 6.70 Perf YTD-11.21%
Dividend Est.- P/FCF- EPS past 5Y- ROI-391.63% 52W High-84.63% Beta0.22
Dividend TTM- Quick Ratio1.10 Sales past 5Y4.38% Gross Margin-30.01% 52W Low21.18% ATR (14)0.08
Dividend Ex-Date- Current Ratio1.13 EPS Y/Y TTM- Oper. Margin-5017.97% RSI (14)52.26 Volatility5.13% 8.72%
Employees64 Debt/Eq0.39 Sales Y/Y TTM- Profit Margin-4979.90% Recom1.00 Target Price5.50
Option/ShortNo / Yes LT Debt/Eq0.30 EPS Q/Q- Payout- Rel Volume0.41 Prev Close0.99
Sales Surprise-45.48% EPS Surprise17.60% Sales Q/Q- EarningsNov 16 BMO Avg Volume88.05K Price1.03
SMA203.15% SMA503.26% SMA200-56.52% Trades Volume35,859 Change4.03%
Date Action Analyst Rating Change Price Target Change
Nov-21-23Downgrade Cantor Fitzgerald Overweight → Neutral
Jun-21-22Initiated H.C. Wainwright Buy $25
Mar-19-24 08:01AM
Mar-18-24 08:01AM
Mar-12-24 08:01AM
Mar-08-24 12:00PM
Mar-05-24 08:01AM
12:54PM Loading…
Feb-28-24 12:54PM
Feb-27-24 08:01AM
Feb-22-24 02:21PM
08:01AM
Feb-21-24 08:01AM
Feb-07-24 12:13PM
Feb-06-24 08:01AM
Feb-01-24 04:17PM
Jan-11-24 08:01AM
Jan-09-24 03:40PM
08:01AM Loading…
08:01AM
Dec-29-23 02:48PM
Dec-19-23 08:01AM
Dec-12-23 08:01AM
Dec-05-23 02:06PM
09:01AM
Nov-29-23 08:01AM
Nov-20-23 08:01AM
Nov-16-23 08:01AM
Nov-15-23 09:01AM
Nov-13-23 09:00AM
Nov-09-23 08:01AM
Nov-07-23 08:01AM
Nov-01-23 08:40AM
Oct-31-23 08:01AM
08:01AM Loading…
Oct-26-23 08:01AM
Oct-18-23 08:01AM
Oct-17-23 03:16PM
Oct-11-23 08:01AM
Oct-10-23 03:53PM
Oct-05-23 08:01AM
Oct-04-23 02:10PM
08:01AM
Sep-27-23 01:43PM
08:01AM
Sep-22-23 02:51PM
Sep-20-23 03:01AM
Sep-13-23 02:31PM
03:01AM
Sep-05-23 02:06PM
03:01AM
Aug-29-23 03:01AM
Aug-22-23 03:01AM
Aug-15-23 03:01AM
Aug-01-23 03:01AM
Jul-18-23 03:01AM
Jun-29-23 03:01AM
Jun-28-23 03:01AM
Jun-20-23 03:01AM
May-31-23 03:01AM
May-24-23 03:01AM
May-21-23 08:08AM
May-16-23 03:01AM
May-10-23 03:01AM
May-03-23 03:01AM
May-01-23 03:01AM
Apr-27-23 03:01AM
Apr-26-23 03:01AM
Apr-10-23 03:01AM
Apr-04-23 03:01AM
Mar-29-23 03:01AM
Mar-21-23 03:01AM
Mar-20-23 02:00PM
Mar-15-23 03:01AM
Mar-08-23 03:01AM
Mar-01-23 03:01AM
Feb-28-23 08:01AM
Feb-21-23 03:01AM
Feb-15-23 03:01AM
Jan-18-23 03:01AM
Jan-03-23 03:01AM
Dec-20-22 03:01AM
Dec-06-22 03:01AM
Nov-29-22 08:00AM
Nov-22-22 08:00AM
Nov-15-22 08:00AM
Nov-02-22 08:00AM
Sep-28-22 07:00AM
Sep-20-22 03:01AM
Sep-07-22 03:01AM
Sep-01-22 03:01AM
Aug-23-22 03:01AM
Aug-16-22 03:01AM
Aug-03-22 07:44AM
03:01AM
Jul-19-22 03:01AM
Jul-12-22 03:01AM
Jul-05-22 03:01AM
Jun-28-22 03:01AM
Jun-14-22 03:01AM
Jun-01-22 03:01AM
May-19-22 03:01AM
May-17-22 03:01AM
May-09-22 08:01AM
May-05-22 03:01AM
Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.